|
US2016174566A1
|
|
Methods, formulations, and kits for bacterial degradation
|
|
US2014243579A1
|
|
Dual-energy image suppression method
|
|
US2014155368A1
|
|
Combination pharmaceuticals and methods thereof using proteinacious channels as treatments for medical conditions
|
|
US2013332198A1
|
|
Systems and Methods for National Registry Data Collection as Patient Care is Conducted
|
|
US2013231262A1
|
|
ENGINEERED PROTEIN: "2-COLOR SERCA", AN ION-MOTIVE ATPase FUSED TO CERULEAN AND YELLOW FLUORESCENT PROTEIN
|
|
WO2013033395A1
|
|
MUTANT HSP70i TO PREVENT AUTOIMMUNE DISEASE
|
|
WO2011150082A2
|
|
Methods of utilizing the arrestin-2/stam-1 complex as a therapeutic target
|
|
WO2011020025A1
|
|
Composition for catalytic amide production and uses thereof
|
|
WO2010111443A2
|
|
Omentum as a source of stromal/stem cells and medical treatments using omentum stromal/stem cells
|
|
US2010167399A1
|
|
Method of generating regulatory t cells using cord blood and adult blood cd14+ monocyte cells
|
|
US2009270658A1
|
|
Methods for preparing aldehydes by self-aldol condensation
|
|
AU2007201791A1
|
|
Papilloma virus capsomere vaccine formulations and methods of use
|
|
AU2006252125A1
|
|
Papiloma virus-like particles, fusion proteins as well as processes for their production
|
|
US7205126B2
|
|
Papilloma pseudovirus and preparation
|
|
WO2005044774A1
|
|
Processes for synthesizing esters by 1,4-addition of alkanoic acids to myrcene or isoprene
|
|
AU2003220535A1
|
|
Plant retroviral polynucleotides and methods for use thereof
|
|
AU2003200653B2
|
|
Papilloma virus capsomere vaccine formulations and methods of use
|
|
US6909010B2
|
|
Facile synthesis of symmetric esters of alkylenebisphosphonic acids
|
|
AU8862801A
|
|
Method and reagents for epithelial barrier formation and treatment of malignant and benign skin disorders by modulating the notch pathway
|
|
US6278016B1
|
|
Methods for conversion of isoprene to prenyl alcohol and related compounds
|
